Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes
The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
Recent studies have implicated fatty acid-dependent activation of the serine kinase IKKβ, which plays a key role in tissue inflammation, in the pathogenesis of insulin resistance. High doses of salicylates have recently been shown to inhibit IKKβ activity and might therefore ameliorate insulin resistance and improve glucose tolerance in patients with type 2 diabetes. To test this hypothesis, we studied nine type 2 diabetic subjects before and after 2 weeks of treatment with aspirin (∼7 g/d). Subjects underwent mixed-meal tolerance tests and hyperinsulinemic-euglycemic clamps with [6,6-2H2]glucose to assess glucose turnover before and after treatment. High-dose aspirin treatment resulted in a ∼25% reduction in fasting plasma glucose, associated with a ∼15% reduction in total cholesterol and C-reactive protein, a ∼50% reduction in triglycerides, and a ∼30% reduction in insulin clearance, despite no change in body weight. During a mixed-meal tolerance test, the areas under the curve for plasma glucose and fatty acid levels decreased by ∼20% and ∼50%, respectively. Aspirin treatment also resulted in a ∼20% reduction in basal rates of hepatic glucose production and a ∼20% improvement in insulin-stimulated peripheral glucose uptake under matched plasma insulin concentrations during the clamp. In conclusion, these data support the hypothesis that IKKβ represents a new target for treating type 2 diabetes mellitus.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In contrast, inhibition or inactivation of JNK (18,26) or IKK (22,24,25,27) improves insulin sensitivity in various models of insulin resistance in association with reduced inhibitory serine phosphorylation of IRS-1 (18).”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [27]
In the citing paper
“Accordingly, KO or inhibition of JNK1 or IKKβ prevents insulin resistance in cell and mouse models (18,22,24,25,87) as well as human models (27) of insulin resistance.”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [27]
In the citing paper
“Moreover, the insulin resistance was ameliorated with salicylates, which also protected against insulin resistance in rodents after acute lipid infusion,127 and reversed insulin resistance in people with type 2 diabetes mellitus.128”
From Lipid-induced insulin resistance: unravelling the mechanism (2010) · cites this paper as [128]
Citations
Cites
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518
Cellular mechanisms of insulin resistance
Shulman, G. I. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10583 · Cited by 2,714
Self-citationYuan, M., Konstantopoulos, N., Lee, J., Hansen, L., Li, Z.-W., Karin, M., & Shoelson, S. E. (2001) · Science · doi:10.1126/science.1061620 · Cited by 1,884
Self-citationRole of Fatty Acids in the Pathogenesis of Insulin Resistance and NIDDM
Boden, G. (1997) · Diabetes · doi:10.2337/diab.46.1.3 · Cited by 1,728
The anti-inflammatory agents aspirin and salicylate inhibit the activity of IκB kinase-β
Yin, M.-J., Yamamoto, Y., & Gaynor, R. B. (1998) · Nature · doi:10.1038/23948 · Cited by 1,590
Mechanism of free fatty acid-induced insulin resistance in humans.
Roden, M., Price, T. B., Perseghin, G., Petersen, K. F., Rothman, D. L., Cline, G. W., & Shulman, G. I. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118742 · Cited by 1,539
Self-citationDresner, A., Laurent, D., Marcucci, M., Griffin, M. E., Dufour, S., Cline, G. W., Slezak, L. A., Andersen, D. K., Hundal, R. S., Rothman, D. L., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5001 · Cited by 1,311
Self-citationGriffin, M. E., Marcucci, M. J., Cline, G. W., Bell, K., Barucci, N., Lee, D., Goodyear, L. J., Kraegen, E. W., White, M. F., & Shulman, G. I. (1999) · Diabetes · doi:10.2337/diabetes.48.6.1270 · Cited by 1,267
Self-citationShulman, G. I., Rothman, D. L., Jue, T., Stein, P., DeFronzo, R. A., & Shulman, R. G. (1990) · New England Journal of Medicine · doi:10.1056/nejm199001253220403 · Cited by 1,248
Self-citationMechanism by which metformin reduces glucose production in type 2 diabetes.
Hundal, R. S., Krssak, M., Dufour, S., Laurent, D., Lebon, V, Chandramouli, V, Inzucchi, S. E., Schumann, W. C., Petersen, K. F., Landau, B. R., et al. (2000) · Diabetes · doi:10.2337/diabetes.49.12.2063 · Cited by 1,052
Self-citation
Research works printed but not linked: 3
- Ebstein, 1877, Berliner Klinische Wochenschrift, 24, 337
- Giugliano, 1982, Diabete Metab, 8, 279
- Shulman, 1990, Am J Physiol, 259, E335
Cited by
Items 201–300 of 554
Flavonoid-rich grapeseed extracts: a new approach in high cardiovascular risk patients?
Kar, P. S., Laight, D. W., Shaw, K. M., & Cummings, M. H. (2006) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2006.01038.x · Cited by 75
Salicylate improves macrophage cholesterol homeostasis via activation of Ampk
Fullerton, M. D., Ford, R. J., McGregor, C., LeBlond, N. D., Snider, S. A., Stypa, S., Day, E. A., Lhoták, Š., Schertzer, J. D., Austin, R. C., et al. (2015) · Journal of Lipid Research · doi:10.1194/jlr.m058875 · Cited by 75
Abundance matters: role of albumin in diabetes, a proteomics perspective
Bhat, S., Jagadeeshaprasad, M. G., Venkatasubramani, V., & Kulkarni, M. J. (2017) · Expert Review of Proteomics · doi:10.1080/14789450.2017.1352473 · Cited by 72
Bhatt, B. A., Dubé, J. J., Dedousis, N., Reider, J. A., & O'Doherty, R. M. (2005) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00097.2005 · Cited by 69
Salsalate improves glycemic control in patients with newly diagnosed type 2 diabetes
Faghihimani, E., Aminorroaya, A., Rezvanian, H., Adibi, P., Ismail‐Beigi, F., & Amini, M. (2011) · Acta Diabetologica · doi:10.1007/s00592-011-0329-2 · Cited by 64
Review article: the metabolic syndrome and non‐alcoholic fatty liver disease
LORIA, P., Lonardo, A., Carulli, L., VERRONE, A. M., Ricchi, M., Lombardini, S., Rudilosso, A., Ballestri, S., & Carulli, N. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02592.x · Cited by 67
Induction of heat shock proteins may combat insulin resistance
McCarty, M. F. (2005) · Medical Hypotheses · doi:10.1016/j.mehy.2004.08.033 · Cited by 69
Myeloid FoxO1 depletion attenuates hepatic inflammation and prevents nonalcoholic steatohepatitis
Lee, S., Usman, T. O., Yamauchi, J., Chhetri, G., Wang, X., Coudriet, G. M., Zhu, C., Gao, J., McConnell, R., Krantz, K., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci154333 · Cited by 64
Shen, H., Shahzad, G., Jawairia, M., Bostick, R. M., & Mustacchia, P. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12944 · Cited by 64
Nuclear factor κB–inducing kinase activation as a mechanism of pancreatic β cell failure in obesity
Malle, E. K., Zammit, N. W., Walters, S. N., Koay, Y. C., Wu, J., Tan, B. M., Villanueva, J. E., Brink, R., Loudovaris, T., Cantley, J., et al. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20150218 · Cited by 63
Nixon, M., Wake, D. J., Livingstone, D. E. W., Stimson, R. H., Esteves, C. L., Seckl, J. R., Chapman, K. E., Andrew, R., & Walker, B. R. (2012) · Diabetes · doi:10.2337/db11-0931 · Cited by 69
Identification and treatment of metabolic complications in pediatric obesity
Ode, K. L., Frohnert, B. I., & Nathan, B. M. (2009) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-009-9115-7 · Cited by 72
Potential Role of Salicylates in Type 2 Diabetes
Rumore, M. M., & Kim, K. S. (2010) · Annals of Pharmacotherapy · doi:10.1345/aph.1m483 · Cited by 65
Hormetic and regulatory effects of lipid peroxidation mediators in pancreatic beta cells
Maulucci, G., Daniel, B., Cohen, O., Avrahami, Y., & Sasson, S. (2016) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2016.03.001 · Cited by 64
Liu, Y., Feng, J., Sun, M., Liu, B., Yang, G., Bu, Y., Zhao, M., Wang, T., Zhang, W., Yuan, H.-F., et al. (2018) · Acta Pharmacologica Sinica · doi:10.1038/s41401-018-0014-x · Cited by 67
Sun, W., Gerhardinger, C., Dagher, Z., Hoehn, T., & Lorenzi, M. (2005) · Diabetes · doi:10.2337/diabetes.54.12.3418 · Cited by 63
Abdin, A. A., Baalash, A., & Hamooda, H. E. (2009) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2009.01.005 · Cited by 62
Butoi, E. D., Tîrcol, M., Mânduțeanu, I., Voinea, M., & Simionescu, M. (2006) · Vascular Pharmacology · doi:10.1016/j.vph.2006.02.006 · Cited by 64
Carvalho-Filho, M. A., Ropelle, E. R., Pauli, R. J., Cintra, D. E., Tsukumo, D. M. L., Silveira, L. R., Curi, R., Carvalheira, J. B. C., Velloso, L. A., & Saad, M. J. A. (2009) · Diabetologia · doi:10.1007/s00125-009-1498-1 · Cited by 63
Lipid induced overexpression of NF-κB in skeletal muscle cells is linked to insulin resistance
Barma, P., Bhattacharya, S., Bhattacharya, A., Kundu, R., Dasgupta, S., Biswas, A., Bhattacharya, S., Roy, S. S., & Bhattacharya, S. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.11.014 · Cited by 59
Diacerhein Improves Glucose Tolerance and Insulin Sensitivity in Mice on a High-Fat Diet
Tobar, N., Oliveira, A. G., Guadagnini, D., Bagarolli, R. A., Rocha, G. Z., Araújo, T. G., Santos-Silva, J. C., Zollner, R. D. L., Boechat, L. H. B., Carvalheira, J. B. C., et al. (2011) · Endocrinology · doi:10.1210/en.2011-0249 · Cited by 63
The stress-responsive protein REDD1 and its pathophysiological functions
Kim, J., Kwon, Y., & Kim, Y. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-01056-3 · Cited by 80
Todd, M. K., Watt, M. J., Le, J., Hevener, A. L., & Turcotte, L. P. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00080.2006 · Cited by 58
The metabolic syndrome as a link between smoking and cardiovascular disease
Dzien, A., Dzien‐Bischinger, C., Hoppichler, F., & Lechleitner, M. (2004) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1462-8902.2004.00324.x · Cited by 57
Kim, J. K. (2012) · Circulation · doi:10.1161/circulationaha.111.090134 · Cited by 55
Bone marrow-CNS connections: Implications in the pathogenesis of diabetic retinopathy
Douglas, J. Y., Bhatwadekar, A. D., Calzi, S. L., Shaw, L. C., Carnegie, D., Caballero, S., Li, Q., Stitt, A. W., Raizada, M. K., & Grant, M. B. (2012) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2012.04.005 · Cited by 54
Metaflammatory responses during obesity: Pathomechanism and treatment
Debnath, M., Agrawal, S., Agrawal, A., & Dubey, G. P. (2015) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2015.10.012 · Cited by 60
Wang, Y., Yan, S., Xiao, B., Zuo, S., Zhang, Q., Chen, G., Yu, Y., Chen, D., Liu, Q., Liu, Y., et al. (2018) · Diabetes · doi:10.2337/db17-1521 · Cited by 57
Tanti, J., Gual, P., Grémeaux, T., Gonzalez, T., Barrès, R., & MARCHAND‐BRUSTEL, Y. L. (2004) · Annales d Endocrinologie · doi:10.1016/s0003-4266(04)95629-6 · Cited by 56
Sugden, M. C., & Holness, M. J. (2004) · Diabetes · doi:10.2337/diabetes.53.2007.s71 · Cited by 60
Role of Cannabinoid Receptor Type 1 in Insulin Resistance and Its Biological Implications
Nagappan, A., Shin, J., & Jung, M. H. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092109 · Cited by 59
A Randomized Trial of Low-Dose Aspirin in the Prevention of Clinical Type 2 Diabetes in Women
Pradhan, A. D., Cook, N. R., Manson, J. E., Ridker, P. M., & Buring, J. E. (2009) · Diabetes Care · doi:10.2337/dc08-1206 · Cited by 52
Gresele, P., & Momi, S. (2006) · Cardiovascular Drug Reviews · doi:10.1111/j.1527-3466.2006.00148.x · Cited by 53
Beta cells in type 2 diabetes – a crucial contribution to pathogenesis
Maedler, K. (2007) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2007.00718.x · Cited by 64
Li, J., Zhang, N., Ye, B., Ju, W., Orser, B. A., Fox, J. E. M., Wheeler, M. B., Wang, Q., & Lu, W. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707259 · Cited by 62
van der Crabben, S. N., Allick, G., Ackermans, M. T., Endert, E., Romijn, J. A., & Sauerwein, H. P. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2491 · Cited by 50
Strauss, S. M., Wheeler, A. J., Russell, S. L., Brodsky, A., Davidson, R. M., Gluzman, R., Lin, L., Malo, R. G., Salis, B., Schoor, R., et al. (2009) · Journal of Periodontology · doi:10.1902/jop.2009.080542 · Cited by 53
Bech-Nielsen, G. V., Hansen, C. H. F., Hufeldt, M. R., Nielsen, D. S., Aasted, B., Vogensen, F. K., Midtvedt, T., & Hansen, A. K. (2011) · Research in Veterinary Science · doi:10.1016/j.rvsc.2011.04.005 · Cited by 53
Pascottini, O. B., Schyndel, S. J. V., Sprícigo, J. F. W., Carvalho, M. R., Mion, B., Ribeiro, E. S., & LeBlanc, S. J. (2020) · Scientific Reports · doi:10.1038/s41598-020-62103-x · Cited by 55
Reappraising the stereotypes of diabetes in the modern diabetogenic environment
Wentworth, J. M., Fourlanos, S., & Harrison, L. C. (2009) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.149 · Cited by 57
Tedong, L., Madiraju, P., Martineau, L. C., Vallerand, D., Arnason, J. T., Désiré, D. D. P., Lavoie, L., Kamtchouing, P., & Haddad, P. S. (2010) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201000045 · Cited by 49
Sun, X., Han, F., Yi, J., Han, L., & Wang, B. (2011) · Journal of Korean Medical Science · doi:10.3346/jkms.2011.26.6.765 · Cited by 49
Weisberg, S. P., Leibel, R. L., & Tortoriello, D. V. (2016) · Nutrition and Diabetes · doi:10.1038/nutd.2016.13 · Cited by 53
Creamer, K. E., Ditmars, F. S., Basting, P. J., Kunka, K. S., Hamdallah, I., Bush, S. P., Scott, Z. W., He, A., Penix, S. R., Gonzales, A. S., et al. (2016) · Applied and Environmental Microbiology · doi:10.1128/aem.02736-16 · Cited by 46
Transcription Factor 7–like 2Polymorphism and Colon Cancer
Slattery, M. L., Folsom, A. R., Wolff, R. K., Herrick, J. S., Caan, B. J., & Potter, J. D. (2008) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-2687 · Cited by 50
Prasad, K., & Lee, P. (2003) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/107424840300800i109 · Cited by 48
Aspirin Targets SIRT1 and AMPK to Induce Senescence of Colorectal Carcinoma Cells
Jung, Y. R., Kim, E. J., Choi, H. J., Park, J.-J., Kim, H.-S., Lee, Y., Park, M., & Lee, M. (2015) · Molecular Pharmacology · doi:10.1124/mol.115.098616 · Cited by 50
Zhong, J., Allen, K. M., Rao, X., Ying, Z., Braunstein, Z., Kankanala, S., Xia, C. Q., Wang, X., Bramble, L. A., Wagner, J. G., et al. (2016) · Inhalation Toxicology · doi:10.1080/08958378.2016.1179373 · Cited by 47
Polonsky, K. S., & Burant, C. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00031-9 · Cited by 73
Involvements of long noncoding RNAs in obesity‐associated inflammatory diseases
Wijesinghe, S. N., Nicholson, T., Tsintzas, K., & Jones, S. W. (2021) · Obesity Reviews · doi:10.1111/obr.13156 · Cited by 47
Chapter 12 Serine Kinases of Insulin Receptor Substrate Proteins
Boura‐Halfon, S., & Zick, Y. (2009) · Vitamins and hormones · doi:10.1016/s0083-6729(08)00612-2 · Cited by 58
An islet in distress: β cell failure in type 2 diabetes
Ogihara, T., & Mirmira, R. G. (2010) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2010.00021.x · Cited by 50
Jiang, G., Dallas-Yang, Q., Biswas, S., Li, Z., & Zhang, B. B. (2004) · Biochemical Journal · doi:10.1042/bj20031207 · Cited by 50
Hypothalamic control of energy and glucose metabolism
Sisley, S. R., & Sandoval, D. A. (2011) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-011-9189-x · Cited by 50
Aspirin in Primary Prevention of Cardiovascular Events
Soodi, D., VanWormer, J. J., & Rezkalla, S. H. (2020) · Clinical Medicine & Research · doi:10.3121/cmr.2020.1548 · Cited by 54
The regulation of muscle protein turnover in diabetes
Workeneh, B., & Bajaj, M. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.06.028 · Cited by 47
Demirdirek, B., & Uhrich, K. E. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.05.047 · Cited by 43
Role of oxidative stress and inflammation in the origin of Type 2 diabetes – a paradigm shift
Pillarisetti, S., & Saxena, U. (2004) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.8.5.401 · Cited by 49
Flores, M. (2005) · Nutrition Research Reviews · doi:10.1079/nrr2005104 · Cited by 49
Khan, A. H., Hwang, S. H., Sharma, A., Corbett, J. A., Hammock, B. D., & Imig, J. D. (2016) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2016.07.003 · Cited by 42
Lumazine Peptides from the Marine-Derived Fungus Aspergillus terreus
You, M., Liao, L., Hong, S. J., Park, W., Kwon, D. I., Lee, J., Noh, M., Oh, D., Oh, K., & Shin, J. (2015) · Marine Drugs · doi:10.3390/md13031290 · Cited by 42
PI3K signaling in the pathogenesis of obesity: The cause and the cure
Beretta, M., Bauer, M. W., & Hirsch, E. (2014) · Advances in Biological Regulation · doi:10.1016/j.jbior.2014.11.004 · Cited by 48
Acute activation of GLP-1-expressing neurons promotes glucose homeostasis and insulin sensitivity
Shi, X., Chacko, S., Li, F., Li, D., Burrin, D., Chan, L., & Guan, X. (2017) · Molecular Metabolism · doi:10.1016/j.molmet.2017.08.009 · Cited by 40
Mazloom, H., Alizadeh, S., Pasalar, P., Nasli‐Esfahani, E., & Meshkani, R. (2015) · Cytokine · doi:10.1016/j.cyto.2015.07.007 · Cited by 44
Dynamic Interplay Between Metabolic Syndrome and Immunity
Paragh, G., Seres, I., Harangi, M., & Fülöp, P. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-07320-0_13 · Cited by 44
Salicylate Blocks Lipolytic Actions of Tumor Necrosis Factor-α in Primary Rat Adipocytes
Zu, L., Jiang, H., He, J., Xu, C. B., Pu, S., Liu, M., & Xu, G. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.039479 · Cited by 40
Jung, T. W., Choi, H. Y., Lee, S. Y., Hong, H. C., Yang, S. J., Yoo, H. J., Youn, B.-S., Baik, S. H., & Choi, K. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066529 · Cited by 39
Molecular and Signaling Mechanisms of Atherosclerosis in Insulin Resistance
Schwartz, E. A., & Reaven, P. D. (2006) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2006.06.005 · Cited by 40
Nie, L., Yuan, X., Jiang, K., Jiang, Y., Yuan, J., Luo, L., Cui, S., & Sun, C. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.08.004 · Cited by 38
Activation of the cAMP-PKA pathway Antagonizes Metformin Suppression of Hepatic Glucose Production
He, L., Chang, E., Peng, J., An, H., McMillin, S. M., Radovick, S., Stratakis, C. A., & Wondisford, F. E. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.719666 · Cited by 40
Essential Minerals and Metabolic Adaptation of Immune Cells
Alghamdi, M. A., Gutierrez, J., & Komarnytsky, S. (2022) · Nutrients · doi:10.3390/nu15010123 · Cited by 52
Butoi, E. D., Mânduțeanu, I., Voinea, M., Costache, G., Manea, A., & Simionescu, M. (2004) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2004.03.003 · Cited by 41
Genetic Basis of Metabolic Abnormalities in Polycystic Ovary Syndrome: Implications for Therapy
Rold??n, B., n, J. L. S. M., & Escobar-Morreale, H. F. (2004) · American Journal of PharmacoGenomics · doi:10.2165/00129785-200404020-00004 · Cited by 46
Kiràly, M. A., Campbell, J. E., Park, E., Bates, H. E., Yue, J. T. Y., Rao, V., Matthews, S. G., Bikopoulos, G. J., Rozakis-Adcock, M., Giacca, A., et al. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90575.2008 · Cited by 42
Atherogenic dyslipidemia and cardiovascular risk in children with nonalcoholic fatty liver disease
Alkhouri, N., Carter-Kent, C. A., Elias, M., & Feldstein, A. E. (2011) · Clinical Lipidology · doi:10.2217/clp.11.19 · Cited by 41
Salicylates Increase Insulin Secretion in Healthy Obese Subjects
Fernández‐Real, J. M., López‐Bermejo, A., Ropero, A. B., Piquer, S., Nadal, Á., Bassols, J., Casamitjana, R., Gomis, R., Arnáiz, E., Pérez, I., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1212 · Cited by 42
The Effect of Salsalate Therapy on Endothelial Function in a Broad Range of Subjects
Nohria, A., Kinlay, S., Buck, J. S., Redline, W., Copeland‐Halperin, R., Kim, S., & Beckman, J. A. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.113.000609 · Cited by 37
Korkmaz‐Icöz, S., Said, S. A., Radovits, T., Li, S., Brune, M., Hegedűs, P., Atmanli, A., Ruppert, M., Brlecic, P., Lehmann, L., et al. (2016) · Cardiovascular Diabetology · doi:10.1186/s12933-016-0383-8 · Cited by 37
Sun, J. L., Park, J., Lee, T., Jeong, J. H., & Jung, T. W. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.113730 · Cited by 34
Acetylsalicylic Acid Improves Lipid-Induced Insulin Resistance in Healthy Men
Möhlig, M., Freudenberg, M., Bobbert, T., Ristow, M., Rochlitz, H., Weickert, M. O., Pfeiffer, A. F. H., & Spranger, J. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1889 · Cited by 36
Grempler, R., Kienitz, A., Werner, T., MEYER, M., Barthel, A., AILETT, F., Sutherland, C. D., Walther, R., & Schmoll, D. (2004) · Biochemical Journal · doi:10.1042/bj20040160 · Cited by 36
Polyactives: controlled and sustained bioactive release via hydrolytic degradation
Stebbins, N. D., Faig, J. J., Yu, W., Guliyev, R., & Uhrich, K. E. (2015) · Biomaterials Science · doi:10.1039/c5bm00051c · Cited by 38
Panahi, G., Pasalar, P., Zare, M., Rizzuto, R., & Meshkani, R. (2018) · PLoS ONE · doi:10.1371/journal.pone.0196580 · Cited by 34
Osteoid osteoma is an osteocalcinoma affecting glucose metabolism
Confavreux, C. B., Borel, O., Lee, F., Vaz, G., Guyard, M., Fadat, C., Carlier, M.-C., Chapurlat, R. D., & Karsenty, G. (2011) · Osteoporosis International · doi:10.1007/s00198-011-1684-0 · Cited by 38
Kim, S. H., Liu, A., Ariel, D., Abbasi, F., Lamendola, C. A., Grove, K., Tomasso, V., Ochoa, H., & Reaven, G. M. (2014) · Diabetes Care · doi:10.2337/dc13-2977 · Cited by 34
Jung, T. W., Lee, S. Y., Hong, H. C., Choi, H. Y., Yoo, H. J., Baik, S. H., & Choi, K. M. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.09.013 · Cited by 35
Prostaglandin in the ventromedial hypothalamus regulates peripheral glucose metabolism
Lee, M., Matsunaga, H., Sugiura, Y., Hayasaka, T., Yamamoto, I., Ishimoto, T., Imoto, D., Suematsu, M., Iijima, N., Kimura, K., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22431-6 · Cited by 35
Diet‐induced obesity impairs AKT signalling in the retina and causes retinal degeneration
Marçal, A. C., Leonelli, M., Fiamoncini, J., Deschamps, F. C., Rodrigues, M. A. M., Curi, R., Carpinelli, Â. R., Britto, L. R. G., & Carvalho, C. R. D. O. (2012) · Cell Biochemistry and Function · doi:10.1002/cbf.2861 · Cited by 37
Paseban, M., Mohebbati, R., Niazmand, S., Sathyapalan, T., & Sahebkar, A. (2019) · Biomolecules · doi:10.3390/biom9040118 · Cited by 35
van Diepen, J. A., Vroegrijk, I. O. C. M., Berbée, J. F. P., Shoelson, S. E., Romijn, J. A., Havekes, L. M., Rensen, P. C. N., & Voshol, P. J. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00185.2011 · Cited by 34
Self-citationREDD1 promotes obesity-induced metabolic dysfunction via atypical NF-κB activation
Lee, D., Kim, T., Byeon, J., Park, M., Kim, S., Kim, J., Choi, S., Lee, G., Park, C., Lee, K. W., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34110-1 · Cited by 35
Resveratrol prevents insulin resistance caused by short-term elevation of free fatty acids in vivo
Pereira, S., Park, E., Moore, J., Faubert, B., Breen, D. M., Oprescu, A. I., Nahle, A., Kwan, D., Giacca, A., & Tsiani, E. (2015) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2015-0075 · Cited by 37
Amelioration of glucose tolerance by hepatic inhibition of nuclear factor κB in db/db mice
Tamura, Y., Ogihara, T., Uchida, T., Ikeda, F., Kumashiro, N., Nomiyama, T., Sato, F., Hirose, T., Tanaka, Y., Mochizuki, H., et al. (2006) · Diabetologia · doi:10.1007/s00125-006-0467-1 · Cited by 36
PKC-mediated modulation of L-type calcium channels may contribute to fat-induced insulin resistance
McCarty, M. F. (2005) · Medical Hypotheses · doi:10.1016/j.mehy.2004.08.034 · Cited by 34
Weismann, D., Erion, D. M., Ignatova-Todorava, I., Nagai, Y., Stark, R., Hsiao, J. J., Flannery, C. A., Birkenfeld, A. L., May, T., Kahn, M., et al. (2010) · Diabetologia · doi:10.1007/s00125-010-1984-5 · Cited by 38
Self-citationAutoamplification of Tumor Necrosis Factor-α
Neels, J. G., Pandey, M., Hotamışlıgil, G. S., & Samad, F. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.050699 · Cited by 30
Potential utility of natural polyphenols for reversing fat-induced insulin resistance
McCarty, M. F. (2004) · Medical Hypotheses · doi:10.1016/j.mehy.2003.11.042 · Cited by 30
Association between systemic immune-inflammation index and insulin resistance and mortality
Deng, X., Liu, D., Li, M., He, J., & Fu, Y. (2024) · Scientific Reports · doi:10.1038/s41598-024-51878-y · Cited by 30
Hommelberg, P. P. H., LANGEN, R. C. J., Schols, A. M. W. J., Mensink, R. P., & Plat, J. (2010) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e32833f1acd · Cited by 31
Role and mechanism of specialized pro-resolving mediators in obesity-associated insulin resistance
Liu, X., Tang, Y., Luo, Y., Gao, Y., & He, L. (2024) · Lipids in Health and Disease · doi:10.1186/s12944-024-02207-9 · Cited by 30
Metadata
- Authors
- Hundal, R. S., Petersen, K. F., Mayerson, A. B., Randhawa, P. S., Inzucchi, S., Shoelson, S. E., & Shulman, G. I.
- Affiliations
- Yale University (US)
- Joslin Diabetes Center (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Shulman, Gerald I.
- Venue
- Journal of Clinical Investigation
- Published
- 2002-05-15
- Volume
- 109
- Issue
- 10
- Pages
- 1321-1326
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W4246592598
- Cited by
- 557
- References
- 24
- Citations by year
- 2026: 5 · 2025: 7 · 2024: 21 · 2023: 17 · 2022: 12 · 2021: 11 · 2020: 19 · 2019: 12 · 2018: 21 · 2017: 17 · 2016: 24 · 2015: 32 · 2014: 33 · 2013: 24 · 2012: 24
- FWCI
- 16.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Funders
- Yale University
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- high-dose aspirin, salicylates, type 2 diabetes, glucose metabolism, insulin resistance, IKKβ, serine kinase, fatty acid signaling, glucose turnover, hepatic glucose production, insulin-stimulated glucose uptake, hyperinsulinemic-euglycemic clamp, mixed meal tolerance test, C-reactive protein, triglycerides, cholesterol
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.